Antihypertensive efficacy and safety of a standardized herbal medicinal product of Hibiscus sabdariffa and Olea europaea extracts (NW Roselle): A phase-II, randomized, double-blind, captopril-controlled clinical trial
- PMID: 32725873
- DOI: 10.1002/ptr.6792
Antihypertensive efficacy and safety of a standardized herbal medicinal product of Hibiscus sabdariffa and Olea europaea extracts (NW Roselle): A phase-II, randomized, double-blind, captopril-controlled clinical trial
Abstract
Hypertension is a public health concern that needs immediate attention upon diagnosis. The demand for natural alternatives is on the rise; Hibiscus sabdariffa and Olea europaea are traditionally used for hypertension management in Egypt. In this study, we aimed to investigate the antihypertensive efficacy and safety of two doses of an herbal product of Hibiscus sabdariffa calyxes and Olea europaea leaves (NW Roselle) in Egyptian patients with grade 1 essential hypertension. We equally randomized 134 patients to receive captopril 25 mg, low-dose NW Roselle, or high-dose NW Roselle BID for 8 weeks. No significant decrease was found in systolic blood pressure or diastolic blood pressure when we compared low-dose NW Roselle and high-dose NW Roselle to captopril (p > .05). In all groups, mean reduction in BP at 8 weeks was significant; 16.4/9.9 mmHg (p < .0001), 15.4/9.6 mmHg (p < .0001), and 14.9/9.4 mmHg (p < .0001) with captopril, low-dose NW Roselle, and high-dose NW Roselle respectively. In addition, low-dose NW Roselle induced a significant reduction in the mean level of triglycerides (17.56 mg/dL; p = .038). In conclusion, NW Roselle had comparable antihypertensive efficacy and safety to captopril in Egyptian patients with grade 1 essential hypertension.
Keywords: cardiovascular; hypertension; lipids; pharmacodynamics; traditional medicine Africa.
© 2020 John Wiley & Sons, Ltd.
References
REFERENCES
-
- Ali, B. H., Al Wabel, N., & Blunden, G. (2005). Phytochemical, pharmacological and toxicological aspects of Hibiscus sabdariffa L.: A review. Phytotherapy Research, 19(5), 369-375. https://doi.org/10.1002/ptr.1628
-
- Alwan, A., Armstrong, T., & Cowan, M. R. L. (2011). Non communicable diseases country profiles 2011 (pp. 1-207). Geneva, Switzerland: World Health Organization. https://doi.org/10.2471/BLT.07.045138
-
- Alwan, A., MacLean, D. R., Riley, L. M., D'Espaignet, E. T., Mathers, C. D., Stevens, G. A., & Bettcher, D. (2010). Monitoring and surveillance of chronic non-communicable diseases: Progress and capacity in high-burden countries. The Lancet, 376(9755), 1861-1868. https://doi.org/10.1016/S0140-6736(10)61853-3
-
- Arauz-Pacheco, C., Parrott, M. A., & Raskin, P. (2002). The treatment of hypertension in adult patients with diabetes. Diabetes Care, 25(1), 134-147. https://doi.org/10.2337/diacare.25.1.134
-
- Asgary, S., Soltani, R., Zolghadr, M., Keshvari, M., & Sarrafzadegan, N. (2016). Evaluation of the effects of roselle (Hibiscus sabdariffa L.) on oxidative stress and serum levels of lipids, insulin and hs-CRP in adult patients with metabolic syndrome: A double-blind placebo-controlled clinical trial. Journal of Complementary and Integrative Medicine, 13(2), 175-180. https://doi.org/10.1515/jcim-2015-0030
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
